WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 8'7401 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 12'9431 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 4'805  4'738  4'670  4'601  4'533  3'930  3'079  2'348 
Births 74  74  73  73  74  79  83  71 
Surviving infants 73  73  73  73  73  78  82  69 
Pop. less than 5 years 361  360  364  367  372  394  411  319 
Pop. less than 15 years 1'150  1'156  1'163  1'172  1'181  1'236  1'103  881 
Female 15-49 years 1'306  1'293  1'277  1'260  1'241  1'042  774  573 

Number of reported case

(Click for retrospective incidence data for Costa Rica)
Diphtheria
Japanese encephalitis
Measles 76  1'000 
Mumps 30  17  25  419 
Pertussis 130  79  71  664  2'024  23  75  960 
Polio*
Rubella 86 
Rubella (CRS) 46 
Tetanus (neonatal)
Tetanus (total) 17 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Costa Rica)
Vaccine year result method % card seen                                                
BCG 1992  96       78  78  77  81  86  92  92  80 
DTP1 1992  94       92  87  83  91  91  90 
DTP3 1992  87       91  85  88  86  89  88  95  86 
HepB_BD          90 
HepB3          91  84  89  87  88  89 
Hib3          90  81  90  87  88  92 
JapEnc         
MCV 1992  92       90  83  83  81  89  82  90  60 
MCV2          95  80  79  84  89 
PCV1          95 
PCV3          89  68  94  48 
Pol3 1992  86       90  82  93  80  89  80  95  86 
Rota1         
Rota_last         
Rubella1          90  83  83  81  89 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Costa Rica)
BCG 78  78  77  81  90  92  92  80 
DTP1 92  87  96  91  90  90  98  95 
DTP3 91  85  88  86  90  88  95  86 
HepB3 91  84  89  87  89  89 
Hib3 90  81  90  87  87  92 
MCV 90  83  83  81  89  82  90  60 
PCV3 89  68  94  48 
Pol3 90  82  93  80  89  80  95  86 
Rota_last

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 64
From 80 to 89% 21
From 50 to 79% 15
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 15 months; Yes
DTaPIPV 4 years; Yes
HepB birth; 2, 6 months; Yes and adults at risk
Influenza > 65 years; Yes and children at risk (6 months) and other at risk groups
MMR 15 months; 6 years; Yes
Pneumo_conj 2, 4, 15 months; Yes
Pneumo_ps 65 years; Yes
Rabies When appropriate
Td 10 years; Yes
Tdap postpartum
Varicella 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  No   
What years does the MYP cover? number     2'011         
Nº of districts with microplans that include activities to raise immunization coverage number 103  103    104  104   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  Yes  Yes         

System performance

Total number of districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 69  54  70  68  71  71 
% of districts with DTP3 coverage >=80% From 0 to 100% 85  67  86  84  88  88 
Nº districts with measles (MCV1) coverage >=95% number 37  23  33  29  21     
% of districts with MCV1 coverage >=95% From 0 to 100% 46  28  41  36  26     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  19  100   

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.